Picture of China Medical System Holdings logo

867 — China Medical System Holdings News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Brief: China Medical System Gains Exclusive License For Oral Small-Molecule Jak1 Inhibitor Povorcitinib

April 1 (Reuters) - China Medical System Holdings Ltd
 0867.HK :
    * GAINING EXCLUSIVE LICENSE FOR ORAL SMALL-MOLECULE JAK1
INHIBITOR
POVORCITINIB
    * GROUP, VIA UNIT, ENTERED A COLLABORATION AND LICENSE
AGREEMENT
WITH INCYTE CORP
    * COLLABORATION AND LICENSE AGREEMENT FOR SELECTIVE ORAL
SMALLMOLECULE JAK1 INHIBITOR POVORCITINIB

Further company coverage:  0867.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on China Medical System Holdings

See all news